BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8578805)

  • 1. Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential.
    Gorringe AR; Borrow R; Fox AJ; Robinson A
    Vaccine; 1995 Sep; 13(13):1207-12. PubMed ID: 8578805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains.
    Ala'Aldeen DA; Borriello SP
    Vaccine; 1996 Jan; 14(1):49-53. PubMed ID: 8821649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation and antigenic cross-reactivity of the transferrin-binding proteins of Haemophilus influenzae, Actinobacillus pleuropneumoniae and Neisseria meningitidis.
    Holland J; Parsons TR; Hasan AA; Cook SM; Stevenson P; Griffiths E; Williams P
    Microbiology (Reading); 1996 Dec; 142 ( Pt 12)():3505-13. PubMed ID: 9004513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design.
    Ala'Aldeen DA; Stevenson P; Griffiths E; Gorringe AR; Irons LI; Robinson A; Hyde S; Borriello SP
    Infect Immun; 1994 Jul; 62(7):2984-90. PubMed ID: 8005685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines.
    Lissolo L; Maitre-Wilmotte G; Dumas P; Mignon M; Danve B; Quentin-Millet MJ
    Infect Immun; 1995 Mar; 63(3):884-90. PubMed ID: 7868259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-protective vaccine.
    Ala'Aldeen DA
    J Med Microbiol; 1996 Apr; 44(4):237-43. PubMed ID: 8606350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the human Ig isotype response to individual transferrin binding proteins A and B from Neisseria meningitidis.
    Johnson AS; Gorringe AR; Fox AJ; Borrow R; Robinson A
    FEMS Immunol Med Microbiol; 1997 Oct; 19(2):159-67. PubMed ID: 9395061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo human immune response to transferrin-binding protein 2 and other iron-regulated proteins of Neisseria meningitidis.
    Ferreirós CM; Ferrón L; Criado MT
    FEMS Immunol Med Microbiol; 1994 Jan; 8(1):63-8. PubMed ID: 8156052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic relationships of transferrin-binding proteins from Neisseria meningitidis, N. gonorrhoeae and Haemophilus influenzae: cross-reactivity of antibodies to NH2-terminal peptides.
    Griffiths E; Stevenson P; Byfield P; Ala'Aldeen DA; Borriello SP; Holland J; Parsons T; Williams P
    FEMS Microbiol Lett; 1993 May; 109(1):85-91. PubMed ID: 8319886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals.
    Danve B; Lissolo L; Mignon M; Dumas P; Colombani S; Schryvers AB; Quentin-Millet MJ
    Vaccine; 1993 Sep; 11(12):1214-20. PubMed ID: 8256502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common antigenic domains in transferrin-binding protein 2 of Neisseria meningitidis, Neisseria gonorrhoeae, and Haemophilus influenzae type b.
    Stevenson P; Williams P; Griffiths E
    Infect Immun; 1992 Jun; 60(6):2391-6. PubMed ID: 1587606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking of iron uptake by monoclonal antibodies specific for the Neisseria meningitidis transferrin-binding protein 2.
    Pintor M; Ferrón L; Gómez JA; Gorringe A; Criado MT; Ferreirós CM
    J Med Microbiol; 1996 Oct; 45(4):252-7. PubMed ID: 8849698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains.
    Rokbi B; Mignon M; Maitre-Wilmotte G; Lissolo L; Danve B; Caugant DA; Quentin-Millet MJ
    Infect Immun; 1997 Jan; 65(1):55-63. PubMed ID: 8975892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human antibody responses to A and C capsular polysaccharides, IgA1 protease and transferrin-binding protein complex stimulated by infection with Neisseria meningitidis of subgroup IV-1 or ET-37 complex.
    Brieske N; Schenker M; Schnibbe T; Quentin-Millet MJ; Achtman M
    Vaccine; 1999 Feb; 17(7-8):731-44. PubMed ID: 10067678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis.
    Ferron L; Ferreiros CM; Criado MT; Pintor M
    Infect Immun; 1992 Jul; 60(7):2887-92. PubMed ID: 1612755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adjuvants in the isotypes and bactericidal activity of antibodies against the transferrin-binding proteins of Neisseria meningitidis.
    Gómez JA; Hernández E; Criado MT; Ferreirós CM
    Vaccine; 1998 Oct; 16(17):1633-9. PubMed ID: 9713939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody studies in mice of outer membrane antigens for use in an improved meningococcal B and C vaccine.
    Milagres LG; Cristina M; Brandileone MC; Sacchi CT; Vieira VS; Zanella RC; Frasch CE
    FEMS Immunol Med Microbiol; 1996 Jan; 13(1):9-17. PubMed ID: 8821393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2.
    Legrain M; Mazarin V; Irwin SW; Bouchon B; Quentin-Millet MJ; Jacobs E; Schryvers AB
    Gene; 1993 Aug; 130(1):73-80. PubMed ID: 8344530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
    Finney M; Vaughan T; Taylor S; Hudson MJ; Pratt C; Wheeler JX; Vipond C; Feavers I; Jones C; Findlow J; Borrow R; Gorringe A
    Hum Vaccin; 2008; 4(1):23-30. PubMed ID: 17921703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of laboratory models in the analysis of TBP2 and other meningococcal antigens.
    Ferrón L; Ferreirós CM; Criado MT; Pintor M
    FEMS Immunol Med Microbiol; 1994 Oct; 9(4):299-305. PubMed ID: 7866351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.